HNGE Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$92.67median target· current $74.73 (+24.0%)16 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
49 articles · sorted by datePage 1 of 3 · 49 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio—Forward 31.35
EPS (TTM)$-8.91-68.4% YoY
Profit margin-78.9%HEALTHCARE
Market cap$5.78BMid cap
Valuation
- Forward P/E
- 31.35
- PEG ratio
- —
- P/B
- 51.76
- P/S (TTM)
- 8.94
- EV/EBITDA
- 226.55
Profitability & growth
- ROE (TTM)
- -136.0%
- Operating margin
- 17.6%
- Revenue growth YoY
- 47.2%
- Dividend yield
- —
- Beta
- —
Last earnings
May 5, 2026 · Estimate $0.40 · Reported $0.45
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Hinge Health, Inc.
Company profileHinge Health, Inc. develops health care software for joint and muscle health. The company is headquartered in San Francisco, California.
Classification
- Sector
- Healthcare
- Industry
- Health Information Services
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 455 MARKET STREET, SAN FRANCISCO, CA
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$5.78B
Shares outstanding$54.7M
52W high$91.50
52W low$30.08
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent